Shares in Black Diamond Therapeutics rose after the company outlined positive initial data from Phase 2 trials of BDTX-1535, an oral cancer treatment. Shares were up 46% in premarket trading at $6.94.

Elevation Oncology has won Food and Drug Administration fast-track designation for EO-3021, its lead drug candidate, in certain patients with gastrointestinal cancers.

Oil futures edged higher early Monday, attempting to build on last week's strong gains, which were scored after the Federal Reserve cut interest rates and investors monitored a rise in Middle East ...

All securities issued pursuant to the First Tranche will be subject to a statutory hold period of four months plus one day from the date of issuance, in addition to such other restrictions as may ...

Manchester-Bedford Myoskeletal is currently accepting new patients for evaluation and treatment for medically necessary musculoskeletal conditions that may be covered under some Medicare Advantage ...

PR Newswire unveiled its 2024 State of the Press Release Report, a highly anticipated analysis of press release engagement ...

The worst affected countries, including Czechia, Poland and Romania, were hit by torrential rain from Storm Boris over the ...